MedTrace Logo

Baclofen in Preventing Postoperative Nausea and Vomiting After Bariatric Surgery

NCT05516953 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-04-22

No results posted yet for this study

Summary

This study aims to evaluate the possible efficacy of baclofen on postoperative nausea and vomiting in patient with morbid obesity who will undergo laparoscopic sleeve gastrectomy.

Conditions

  • Postoperative Nausea and Vomiting
  • Laparoscopic Sleeve Gastrectomy
  • Morbid Obesity

Interventions

DRUG

Baclofen Tablets

10 mg oral baclofen 1 h before anesthesia

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Aya Moussa · Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-22
Primary Completion
2024-12-28
Completion
2025-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05516953 on ClinicalTrials.gov